You’re absolutely entitled to your expectations. But let’s separate two things:
1. Credibility of projections
2. Credibility of execution
The former—forward-looking statements—are always subject to change. Not just in biotech, but across every industry.
The latter—what’s been done—can’t be ignored:
***Transgenic silkworms weren’t theory—they’re in production.
***Cocoons aren’t concepts—they’re visible, documented, and scaling.
***Fiber extraction and reeling isn’t fluff—it’s happening.
Disappointment in timing is valid.
Discrediting progress because it didn’t arrive on your schedule? That’s shortsighted.
Credibility isn’t just about calling every shot perfectly. It’s about staying in the fight, evolving under pressure, and not giving up the moment a projection hits resistance.
You still “hope to make a bunch of money?"
Then you might want to consider that the one constant—the CEO you now doubt—is the only reason you still can.
Bullish
Market Data 
Markets 
AI
